Completed PHASE4 INTERVENTIONAL 2-arm NCT03860662

The Effect of Oral Baclofen and Botulinum Toxin Treatments in Hemiplegic Spasticity on the Nociceptive Flexor Reflex

Doctor, Physical Medicine and Rehabilitation

Sponsor: Mustafa Kemal University

Conditions Spastic Hemiplegia Stroke Sequelae

Interventions Baclofen Botox Nociceptor flexor reflex

Updated 7 times since 2019 Last updated: Jun 13, 2021 Started: May 26, 2018 Primary completion: Mar 21, 2019 Completion: Apr 21, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Spastic Hemiplegia and Stroke Sequelae, this trial is completed. The trial is conducted by Mustafa Kemal University and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Not Yet Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE4

▶ Show 2 earlier versions

Feb 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4
Apr 2019 — Feb 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mustafa Kemal University

Data source: Mustafa Kemal University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hatay, Turkey (Türkiye)